Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HEAL
3801
Global X Funds Global X HealthTech ETF
HEAL
$28.5M
| $36K | ﹤0.01% |
+1,031
| New | +$35.8K |
|
3802
Global Partners
GLP
$1.68B
| $35.8K | ﹤0.01% |
1,164
-954
| -45% | -$29.1K |
|
3803
ProShares Short QQQ
PSQ
$824M
| $35.7K | ﹤0.01% |
676
| – | – |
|
3804
Turkcell
TKC
$4.68B
| $35.7K | ﹤0.01% |
10,000
| – | – |
|
3805
Purple Innovation
PRPL
$35.3M
| $35.6K | ﹤0.01% |
513
-2,324
| -82% | -$167K |
|
3806
Ponce Financial Group
PDLB
$488M
| $35.6K | ﹤0.01% |
4,097
+354
| +9% | +$2.76K |
|
|
CWBC
3807
Community West Bancshares
CWBC
$679M
| $35.4K | ﹤0.01% |
2,292
-5,417
| -70% | -$83.9K |
|
3808
C&F Financial
CFFI
$268M
| $35.4K | ﹤0.01% |
+659
| New | +$34.9K |
|
3809
Zevra Therapeutics
ZVRA
$562M
| $35.4K | ﹤0.01% |
6,936
+6,827
| +6,263% | +$36.8K |
|
3810
InfuSystem Holdings
INFU
$184M
| $35.2K | ﹤0.01% |
+3,653
| New | +$33.1K |
|
3811
Parke Bancorp
PKBK
$401M
| $35.1K | ﹤0.01% |
2,068
-3,022
| -59% | -$50.6K |
|
3812
ThredUp
TDUP
$746M
| $34.9K | ﹤0.01% |
14,308
-46,211
| -76% | -$121K |
|
3813
BCB Bancorp
BCBP
$173M
| $34.9K | ﹤0.01% |
2,971
-12,380
| -81% | -$141K |
|
|
KZR
3814
DELISTED
Kezar Life Sciences
KZR
| $34.9K | ﹤0.01% |
1,423
-81,480
| -98% | -$2.12M |
|
3815
Stratus Properties
STRS
$156M
| $34.8K | ﹤0.01% |
1,325
-1,646
| -55% | -$37.3K |
|
3816
Veritone
VERI
$101M
| $34.7K | ﹤0.01% |
8,855
-6,889
| -44% | -$30.1K |
|
|
VOXX
3817
DELISTED
VOXX International Corporation Class A
VOXX
| $34.7K | ﹤0.01% |
2,780
-3,255
| -54% | -$38.5K |
|
3818
Granite Ridge Resources
GRNT
$627M
| $34.6K | ﹤0.01% |
5,225
+4,365
| +508% | +$26.2K |
|
3819
Mastech Digital
MHH
$93.1M
| $34.6K | ﹤0.01% |
3,502
| – | – |
|
3820
Rallybio
RLYB
$84.5M
| $34.5K | ﹤0.01% |
763
-434
| -36% | -$21.3K |
|
3821
NatWest
NWG
$75.4B
| $34.5K | ﹤0.01% |
+5,640
| New | +$37K |
|
3822
FVCBankcorp
FVCB
$335M
| $34.3K | ﹤0.01% |
3,186
-4,351
| -58% | -$43.4K |
|
3823
ProShares UltraShort S&P500
SDS
$415M
| $34.3K | ﹤0.01% |
+200
| New | +$38.4K |
|
3824
CVRx
CVRX
$137M
| $34.2K | ﹤0.01% |
2,216
-54,463
| -96% | -$665K |
|
|
ITI
3825
DELISTED
Iteris, Inc.
ITI
| $34.1K | ﹤0.01% |
+8,620
| New | +$38.5K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.